Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9578 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9458 |
High Similarity |
NPD6797 |
Phase 2 |
0.9401 |
High Similarity |
NPD7251 |
Discontinued |
0.9231 |
High Similarity |
NPD7808 |
Phase 3 |
0.9222 |
High Similarity |
NPD7054 |
Approved |
0.9167 |
High Similarity |
NPD7472 |
Approved |
0.9162 |
High Similarity |
NPD3818 |
Discontinued |
0.9053 |
High Similarity |
NPD7074 |
Phase 3 |
0.9042 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9042 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9042 |
High Similarity |
NPD6166 |
Phase 2 |
0.9024 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8963 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8889 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8882 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8788 |
High Similarity |
NPD3817 |
Phase 2 |
0.8675 |
High Similarity |
NPD5402 |
Approved |
0.8623 |
High Similarity |
NPD3882 |
Suspended |
0.8571 |
High Similarity |
NPD7075 |
Discontinued |
0.8554 |
High Similarity |
NPD1934 |
Approved |
0.8528 |
High Similarity |
NPD1512 |
Approved |
0.8503 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD2801 |
Approved |
0.8476 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8443 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8434 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8409 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8405 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8398 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8393 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8293 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8286 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8212 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8212 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8204 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8166 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8161 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.8136 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.807 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8061 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8057 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8036 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8011 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7989 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7978 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7966 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7958 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7943 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7927 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7923 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7846 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7805 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7801 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7801 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7801 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7801 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7801 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7801 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7801 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7784 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD919 |
Approved |
0.7784 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7737 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7701 |
Intermediate Similarity |
NPD37 |
Approved |
0.7679 |
Intermediate Similarity |
NPD3750 |
Approved |
0.767 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.767 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.767 |
Intermediate Similarity |
NPD4965 |
Approved |
0.767 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7647 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7641 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7641 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7611 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7598 |
Intermediate Similarity |
NPD1247 |
Approved |
0.759 |
Intermediate Similarity |
NPD7697 |
Approved |
0.759 |
Intermediate Similarity |
NPD7698 |
Approved |
0.759 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7588 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD943 |
Approved |
0.7561 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD1613 |
Approved |
0.756 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7551 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7545 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7539 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7539 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7525 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD7240 |
Approved |
0.75 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7475 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7455 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7427 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7413 |
Intermediate Similarity |
NPD7801 |
Approved |
0.741 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7399 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1607 |
Approved |
0.736 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7317 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7316 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD920 |
Approved |
0.7299 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7299 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7299 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7283 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7264 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7256 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7236 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7232 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7214 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7208 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7166 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7128 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7128 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7085 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7045 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7017 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7016 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7011 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD2344 |
Approved |
0.6994 |
Remote Similarity |
NPD1091 |
Approved |
0.6974 |
Remote Similarity |
NPD4287 |
Approved |
0.6971 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD7038 |
Approved |
0.6963 |
Remote Similarity |
NPD7039 |
Approved |
0.6952 |
Remote Similarity |
NPD5242 |
Approved |
0.6946 |
Remote Similarity |
NPD9494 |
Approved |
0.6935 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6927 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6919 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6914 |
Remote Similarity |
NPD6674 |
Discontinued |
0.691 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6898 |
Remote Similarity |
NPD5711 |
Approved |
0.6898 |
Remote Similarity |
NPD5710 |
Approved |
0.6898 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.689 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD2798 |
Approved |
0.6879 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD6386 |
Approved |
0.6868 |
Remote Similarity |
NPD6385 |
Approved |
0.6867
|
Remote Similarity |
NPD3225 |
Approved |